Radiometer Proudly Sponsors 2023 World Sepsis Congress

The 4th World Sepsis Congress will be held virtually on April 25 and 26, 2023 with the theme of: One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance (AMR).

March 31, 2023

Congress attendees can hear from more than 85 interdisciplinary speakers who will discuss Sepsis from various perspectives. Topics will include the role of technology like AI, machine learning, big data; the link to pandemics and AMR; the latest research; policy impacts; and trial designs. This year’s focus is to show the interdependencies between Sepsis, pandemics and antimicrobial resistance.

The two-day Congress will include discussions on the impact of global health threats and tactics for addressing them, industry-driven research and highlights of regional initiatives aimed at addressing Sepsis care. The diverse range of this year’s speakers includes thought leaders, medical professionals, impacted patients and families and policy makers.

Since 2015, Radiometer is a proud supporter of the Global Sepsis Alliance, a non-profit organisation of more than 100 organisations with the mission to provide global leadership, increase awareness, and reduce the worldwide burden of Sepsis. This year, Radiometer will sponsor the World Sepsis Congress, which covers 16 distinctive and highly relevant sessions:

Day 1

Session 1: Key Success Factors to Address Global Health Threats

Session 2: The Health Economic and Human Burden of Infections and Pandemics

Session 3: Overcoming Silos to Address Infection-Related Global Health Threats

Session 4: The Quality of Healthcare Systems and QI Efforts on Outcomes from Sepsis and Pandemics

Session 5: Advances and Challenges by Our Regional Sepsis Alliances

Session 6: Advances in Timely Pathogen and Sepsis Detection

Day 2

Session 7: The Benefits of Multidisciplinary Teams in Sepsis Care on the Health Care Facility Level

Session 8: The Potential and Challenges to Intervene with the Immune Response

Session 9: Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR

Session 10: Lessons from the Pandemic to Fight Common Infections and Sepsis

Session 11: Understanding and Improving Long-Term Outcomes After Sepsis and Covid-19

Session 12: Neonatal Sepsis Platforms and Guidelines

Session 13: The Impact of Survivors and Family Members to Improve Sepsis Awareness and Advocacy

Session 14: Maternal Sepsis: Why is it Still in the Top 3 for Global Incidence of Sepsis?

Session 15: Harnessing the Media to Advance the Global Fight Against Sepsis

Session 16: An Update on Research on Sepsis

Do you have colleagues who would be interested in attending? Please share the news and courage others to join. You can sign up and find more information here.


About Radiometer

Whatever comes next, we make sure life comes first.


Radiometer develops, manufactures, and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems. Today, Radiometer products and solutions are used in hospitals, clinics, and laboratories in over 130 countries, providing information on critical parameters in acute care diagnostics.

Through connected solutions, expert knowledge, and trusted partnership, we help health care professionals make diagnostic decisions to improve patient care.

Cookies are used on this website

Use of cookies
Don't show this message again
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
SIGN IN
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

CLOSE BANNER
Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

TRY AGAIN CONTINUE
Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

RESEND E-MAIL
Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

TRY AGAIN
Sorry

It seems this account has not been given access to the portal

Continue

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
    •    
  • Single-sign on experience
    •    
  • Use same credentials to access future services    

Request access

You will receive an invitation to access our services via e-mail when your request  has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.